Working… Menu

Gene Therapy for Transfusion Dependent Beta-thalassemia (TIGET-BTHAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02453477
Recruitment Status : Unknown
Verified June 2019 by Alessandro Aiuti, IRCCS San Raffaele.
Recruitment status was:  Active, not recruiting
First Posted : May 25, 2015
Last Update Posted : June 28, 2019
Fondazione Telethon
Orchard Therapeutics
Information provided by (Responsible Party):
Alessandro Aiuti, IRCCS San Raffaele

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : August 2019
Estimated Study Completion Date : August 2019